Allergan Reaches Deal To Pay $2.37B To Settle Opioid Suits
Attorneys general announced a $2.37 billion national settlement with AbbVie unit Allergan on Friday to end litigation over the opioid crisis, just days after Teva announced a similar opioid deal worth...To view the full article, register now.
Already a subscriber? Click here to view full article